Form 8-K - Current report:
SEC Accession No. 0000950170-25-070899
Filing Date
2025-05-14
Accepted
2025-05-14 07:01:13
Documents
13
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K spry-20250514.htm   iXBRL 8-K 54423
2 EX-99.1 spry-ex99_1.htm EX-99.1 259145
3 GRAPHIC img41264513_0.jpg GRAPHIC 193841
  Complete submission text file 0000950170-25-070899.txt   725700

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT spry-20250514.xsd EX-101.SCH 32095
15 EXTRACTED XBRL INSTANCE DOCUMENT spry-20250514_htm.xml XML 4893
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 25942592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)